Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organicell Regenerative Medicine Inc (OP: OCEL )

0.0130 +0.0027 (+26.21%)
Streaming Delayed Price Updated: 12:05 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Organicell Regenerative Medicine Inc

Recent Report Shows That Extracellular Vesicles Might Also Be Key To Stopping COVID, Colds, And Other Nasal Viruses
By Rachael Green, Benzinga 
Via News Direct
Exposures COVID-19 Product Safety
Recent Report Shows That Extracellular Vesicles Might Also Be Key To Stopping COVID, Colds, And Other Nasal Viruses
To learn more about Organicell, download the latest research report here 
Via Benzinga
Organicell Regenerative Medicine Broadens Access to Valued Business Expertise and Relationship With New Additions to Board of Directors
Organicell Regenerative Medicine, Inc. (OTCQB: OCEL) recently announced that the Company has added independent board members to its board of directors. 
Via Benzinga
Organicell Regenerative Medicine, Inc. Announces Expansion into Health and Beauty Market
 
Via Benzinga
Pharma Company Organicell Partners With Beauty Health Focusing On Aging & Inflammation Signs
 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.